Article AbstractLetter to the Editor Sir: It has been our clinical experience that serotonin reuptake inhibitors (SRIs) rapidly improve the symptom of excessive or inappropriate crying in depressed patients. This is consistent with reports in which SRIs improve pathologic crying in stroke patients. We, however, report three cases in which patients complained that they were unable to cry during SRI treatment. We know of no previous reports of this SRI-induced adverse effect.
No takes yet. Share an insight, caveat, or question.
Oleshansky et al. (1996) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: